Letter to the Editor
Acute kidney injury with sodium-glucose co-transporter-2 inhibitors across the cardiovascular and renal outcome trials: Foe or friend?
Daño renal agudo con cotransportador de sodio-glucosa-2 inhibidores en el resultado cardiovascular y renal ensayos: enemigo o amigo?
Dimitrios Patouliasa,
, Christodoulos Papadopoulosb, Fotios Siskosa, Michael Doumasa,c
Corresponding author
a Second Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, General Hospital “Hippokration”, Greece
b Third Department of Cardiology, Aristotle University of Thessaloniki, General Hospital “Hippokration”, Greece
c Veterans Affairs Medical Center, George Washington University, Washington, District of Columbia, United States
Read
7040
Timeswas read the article
1977
Total PDF
5063
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 May | 57 | 13 | 70 |
| 2024 April | 167 | 53 | 220 |
| 2024 March | 152 | 29 | 181 |
| 2024 February | 430 | 49 | 479 |
| 2024 January | 2793 | 1368 | 4161 |
| 2023 December | 937 | 63 | 1000 |
| 2023 November | 54 | 37 | 91 |
| 2023 October | 60 | 36 | 96 |
| 2023 September | 67 | 33 | 100 |
| 2023 August | 43 | 25 | 68 |
| 2023 July | 43 | 38 | 81 |
| 2023 June | 32 | 16 | 48 |
| 2023 May | 36 | 32 | 68 |
| 2023 April | 27 | 25 | 52 |
| 2023 March | 31 | 27 | 58 |
| 2023 February | 27 | 24 | 51 |
| 2023 January | 36 | 45 | 81 |
| 2022 December | 54 | 42 | 96 |
| 2022 November | 17 | 22 | 39 |
Show all
